Viable germ cell tumor (GCT) identified at postchemotherapy retroperitoneal lymph node dissection (PC-RPLND): The significance of risk assignment and adjuvant chemotherapy

被引：1
|
作者：
Karanikolas, NT
Serio, A
Vickers, AJ
Carver, BS
Stephenson, AJ
Bosl, GJ
Joel, S
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)32836-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
590
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [11] Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
    Tachibana, Isamu
    Alabd, Andre
    Whaley, Rumeal D.
    McFadden, Jacob
    Piroozi, Alex
    Hassoun, Rebecca
    Kern, Sean Q.
    King, Jennifer
    Adra, Nabil
    Rice, Kevin R.
    Foster, Richard S.
    Einhorn, Lawrence H.
    Cary, Clint
    Masterson, Timothy A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 394.e1 - 394.e6
  • [12] Comparing the perioperative management of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with pure seminomatous and non seminomatous germ cell tumours, NSGCT
    Pfister, D.
    Albers, P.
    Busch, J.
    Dieckmann, K-P
    Schmelz, H.
    Krege, S.
    Winter, C.
    Schrader, M.
    Honecker, F.
    Heidenreich, A.
    ONKOLOGIE, 2013, 36 : 81 - 81
  • [13] PATHOHISTOLOGICAL FINDINGS IN PATIENTS WITH NONSEMINOMATOUS GERM CELL TUMOURS (NSGCT) WHO UNDERGO POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) FOR SMALL TUMOURS
    Pfister, David
    Busch, Jonas
    Winter, Christian
    Albers, Peter
    Schrader, Mark
    Dieckmann, Klaus-Peter
    Krege, Susanne
    Schmelz, Hans
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2011, 185 (04): : E334 - E334
  • [14] Pathohistologic findings in patients with nonseminnomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumors
    Pfister, D. J.
    Busch, J.
    Winter, C.
    Schmelz, H. U.
    Dieckmann, K.
    Albers, P.
    Schrader, M.
    Heldenreich, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [15] POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) FOR SEMINOMA: IS SURGERY EFFECTIVE?
    Tachibana, Isamu
    Alabd, Andre
    Whaley, Rumeal
    Mcfadden, Jacob
    Piroozi, Alex
    Kern, Sean
    Adra, Nabil
    Foster, Richard
    Einhorn, Lawrence
    Cary, Clint
    Masterson, Timothy
    JOURNAL OF UROLOGY, 2023, 209 : E687 - E688
  • [16] Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
    Heidenreich, Axel
    Pfister, David
    Paffenholz, Pia
    Heidenreich, Julian
    Zschaebitz, Stefanie
    Che, Yu
    Cary, Clint
    Hentrich, Prof. Marcus
    Gerdtsson, Axel
    Negaard, Helene F. S.
    Kjellman, Anders
    Albers, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [17] Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
    Heidenreich, Axel
    Daneshmand, Siamak
    Che, Yu
    Pfister, David A.
    Paffenholz, Pia
    Ghoreifi, Alireza
    Zschaebitz, Stefanie
    Hentrich, Marcus
    Thy, Sophia
    Albers, Peter
    Cary, Clint
    Gerdtsson, Axel
    Kjellman, Anders
    Negaard, Helene F. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [18] Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection
    Spiess, Philippe E.
    Tannir, Nizar M.
    Brown, Gordon A.
    Liu, Ping
    Tu, Shi-Ming
    Evans, James G.
    Pisters, Louis L.
    UROLOGY, 2007, 70 (06) : 1173 - 1178
  • [19] Histological and perioperative outcomes of post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) in advanced germ cell turmors - A single center experience
    Lusch, Achim
    Zaum, Martin
    Winter, Christian
    Krauspe, Ruediger
    Grabitz, Klaus
    Albers, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [20] Validation of the two best models to predict "benign" pathohistology in patients with advanced nonseminomatous germ cell tumors (NSGCT) undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)
    Nestler, Tim
    Paffenholz, Pia
    Baessler, Bettina
    Hellmich, Martin
    Hiester, Andreas
    Nini, Alessandro
    Pfister, David
    Albers, Peter
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345